Cargando…
Genome-scale CRISPR screens identify host factors that promote human coronavirus infection
BACKGROUND: The COVID-19 pandemic has resulted in 275 million infections and 5.4 million deaths as of December 2021. While effective vaccines are being administered globally, there is still a great need for antiviral therapies as antigenically novel SARS-CoV-2 variants continue to emerge across the...
Autores principales: | Grodzki, Marco, Bluhm, Andrew P., Schaefer, Moritz, Tagmount, Abderrahmane, Russo, Max, Sobh, Amin, Rafiee, Roya, Vulpe, Chris D., Karst, Stephanie M., Norris, Michael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792531/ https://www.ncbi.nlm.nih.gov/pubmed/35086559 http://dx.doi.org/10.1186/s13073-022-01013-1 |
Ejemplares similares
-
Genome-wide CRISPR
Screen Reveal Targets of Chiral
Gold(I) Anticancer Compound in Mammalian Cells
por: Kim, Jong Hyun, et al.
Publicado: (2022) -
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML
por: Nguyen, Nam H. K., et al.
Publicado: (2022) -
Parabens and Human Epidermal Growth Factor Receptor Ligand Cross-Talk in Breast Cancer Cells
por: Pan, Shawn, et al.
Publicado: (2015) -
Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X(L)–Specific Degrader DT2216
por: Thummuri, Dinesh, et al.
Publicado: (2022) -
Genome-scale CRISPR screen identifies TMEM41B as a multi-function host factor required for coronavirus replication
por: Sun, Limeng, et al.
Publicado: (2021)